Commit 8a618d1e authored by Mathieu Giraud's avatar Mathieu Giraud

Merge branch 'doc/new-publis' into 'dev'

New publications using Vidjil

See merge request !798
parents d06de6d0 2319188f
Pipeline #170233 failed with stages
in 67 minutes and 50 seconds
......@@ -87,6 +87,11 @@ BMC Genomics 2014, 15:409
## Some publications using Vidjil
Chrystelle Abdo et al.,
*Caution encouraged in next-generation sequencing immunogenetic analyses in acute lymphoblastic leukemia*
Blood, 2020, 136(9):1105–1107
Jean-Sebastien Allain et al.,
*IGHV segment utilization in immunoglobulin gene rearrangement differentiates patients with anti-myelin-associated glycoprotein neuropathy from others immunoglobulin M-gammopathies*,
Haematologica, 2018, 103:e207-e210
......@@ -102,6 +107,17 @@ Sébastien Bender et al.,
Blood, 2020,
Roberta Cavagna et al.,
*Capture-based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular Probes*
Cancers, 2020, 12(6), 1505,
Frédéric Davi et al., on behalf of ERIC, the European Research Initiative on CLL, and the EuroClonality-NGS Working Group,
*Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing*
Leukemia, 2020,
Yann Ferret et al.,
*Multi-loci diagnosis of acute lymphoblastic leukaemia with high-throughput sequencing and bioinformatics analysis*,
British Journal of Haematology, 2016, 173, 413–420
......@@ -112,6 +128,11 @@ Henrike J. Fischer et al.,
Journal of Neuroimmunology, 2015, S0165-5728(15)30065-5
Navarro Nilo Giusti et al., 2020
*Test trial of spike-in immunoglobulin heavy-chain (IGH) controls for next generation sequencing quantification of minimal residual disease in acute lymphoblastic leukaemia*
British Journal of Haematology, 2020, 189: e150-e154
Irene Jo et al.,
*Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia*,
Clinica Chimica Acta, 2019,
......@@ -152,11 +173,21 @@ Mikaël Salson et al.,
Leukemia Research, 2017, 53, 1–7
Masashi Sanada et al.,
*Targeted-Capture Sequencing Is a Useful Method for MRD Markers Screening in KMT2A (MLL) Rearranged Leukemia*
Blood, 2019, 134(S1):2759
Florian Scherer et al.,
*Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA*,
Science Translational Medicine, 2016, 8, 364ra155
V. Seitz et al.,
*Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL*
Scientific Reports, 2020, 10: 10024
Udo zur Stadt et al.,
*Characterization of novel, recurrent genomic rearrangements as sensitive MRD targets in childhood B-cell precursor ALL*
Blood Cancer Journal, 2019,
......@@ -167,6 +198,11 @@ Lucia Stranavova et al.,
Frontiers in Immunology, 2019,
Amelie Trinquand et al.,
*Towards molecular stratification of pediatric T-cell lymphoblastic lymphomas based on Minimal Disseminated Disease and NOTCH1/FBXW7 mutational status: the French EURO-LB02 experience (preprint)*
medRxiv 2020.09.08.20189829,
Gary Wright et al.,
*Clinical benefit of a high‐throughput sequencing approach for minimal residual disease in acute lymphoblastic leukemia*,
Pediatric Blood & Cancer, 2019,
......@@ -176,3 +212,8 @@ Wen‐Qing Yao et al.,
*Angioimmunoblastic T‐cell lymphoma contains multiple clonal T‐cell populations derived from a common TET2 mutant progenitor cell*
The Journal of Pathology, 2019,
Yasuda et al.,
*Clinical utility of target capture‐based panel sequencing in hematological malignancies: A multicenter feasibility study*
Cancer Science, 2020, 111(9):3367-3378,
Markdown is supported
0% or
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment